Marker Therapeutics, Inc. (MRKR)
0.885
-0.02
(-1.67%)
USD |
NASDAQ |
Nov 13, 10:40
Marker Therapeutics Net Income (Annual) : -12.16M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -12.16M |
| December 31, 2024 | -10.73M |
| December 31, 2023 | -14.05M |
| December 31, 2022 | -19.78M |
| December 31, 2021 | -41.88M |
| December 31, 2020 | -28.71M |
| December 31, 2019 | -21.43M |
| December 31, 2018 | -147.96M |
| December 31, 2017 | -10.98M |
| December 31, 2016 | -2.455M |
| December 31, 2015 | -34.07M |
| December 31, 2014 | -30.88M |
| December 31, 2013 | -5.533M |
| December 31, 2012 | -6.172M |
| Date | Value |
|---|---|
| December 31, 2011 | -2.029M |
| December 31, 2010 | -5.091M |
| December 31, 2009 | -4.462M |
| December 31, 2008 | -2.196M |
| December 31, 2007 | -3.891M |
| December 31, 2006 | -1.304M |
| December 31, 2005 | -0.9856M |
| December 31, 2004 | -2.683M |
| December 31, 2003 | -5.779M |
| December 31, 2002 | -2.285M |
| December 31, 2001 | -0.3799M |
| December 31, 2000 | |
| December 31, 1999 | -1.127M |
| December 31, 1998 | -0.4167M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Rigel Pharmaceuticals, Inc. | 367.02M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |